State-of-the-art chemoradiation is no substitution for trimodality approach in the treatment of locally advanced thoracic esophageal squamous cell carcinoma

Asian J Surg. 2023 Aug;46(8):3383-3384. doi: 10.1016/j.asjsur.2023.03.094. Epub 2023 Mar 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / therapy
  • Chemoradiotherapy
  • Combined Modality Therapy
  • Esophageal Neoplasms* / surgery
  • Esophageal Squamous Cell Carcinoma* / pathology
  • Esophageal Squamous Cell Carcinoma* / therapy
  • Esophagectomy
  • Humans
  • Neoadjuvant Therapy
  • Neoplasm Staging